Home News CLS CEO on Q2 and upcoming milestones

CLS CEO on Q2 and upcoming milestones

CLS vd Dan Mogren i korridoren på Medicon Village, Lund
Dan Mogren, vd för CLS

CLS CEO on Q2 and upcoming milestones

28 August, 2023

Medtech Clinical Laserthermia Systems published its report for the second quarter on Friday. CEO Dan Mogren visited BioStock’s studio to talk about the past quarter, tell us more about the company’s financial status and for a look at upcoming milestones.

Watch the interview with CLS CEO Dan Mogren below.

YouTube video

Read more about CLS här.

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.

Prenumerera på BioStocks nyhetsbrev